Connecting Type 1 and Type 2 diabetes through innate immunity. The risk of death in 2019 novel coronavirus disease (COVID-19) in Hubei Province. Int J Evid Based Healthc. Sci Rep. 2017;7:1–9. Community case clusters of middle east respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. CrossRefZurück zum Zitat Higgins JPT, Thompson SG. MedRxiv. 2017;21:597–605.
2020. https://www.medrxiv.org/content/10.1101/2020.02.26.20028589v1https://www.medrxiv.org/content/10.1101/2020.02.26.20028589v1Zurück zum Zitat Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: a systematic review. 2020. https://doi.org/10.1101/2020.03.04.20030395. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. CrossRefPubMedPubMedCentralZurück zum Zitat Odegaard JI, Chawla A. Diabetes Metab Res Rev. CrossRefPubMedPubMedCentralhttps://doi.org/10.1016/j.kint.2020.03.005Zurück zum Zitat Fu L, Fei J, Xiang H-X, Xiang Y, Tan Z-X, Li M-D, et al. 1994;50:1088–101. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Emerg Infect Dis. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau.
2019;147:4. N Engl J Med. CrossRefPubMedPubMedCentralhttps://doi.org/10.1016/j.ijcard.2020.03.063Zurück zum Zitat Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. CrossRefZurück zum Zitat Assiri A, Abedi GR, Saeed AAB, Abdalla MA, Choudhry AJ, Lu X, et al. https://doi.org/10.1001/jama.2020.4683.Zurück zum Zitat Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Improved tests for a random effects meta-regression with a single covariate. Clin Oral Investig. 2012;2:e000809. Gastroenterology. Coronavirus (COVID-19). CrossRefZurück zum Zitat Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Stat Med. 2016;22:32–40. I clocked my card way to high, and left the PC destroyed. CrossRefPubMedPubMedCentralZurück zum Zitat Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. 2015;35:203–9. J Med Virol. 2020;92:797–806. 2020;323:1061–9. 1998;42:16–22.Zurück zum Zitat Knapp G, Hartung J.
2020;14:115. https://doi.org/10.14309/ajg.0000000000000620.https://doi.org/10.14309/ajg.0000000000000620Zurück zum Zitat Cao M, Zhang D, Wang Y, Lu Y, Zhu X, Li Y, et al. Preliminary estimates of the prevalence of selected underlying health conditions among patents with coronavirus disease 2019- United States, February 12-March 28, 2020.
Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study. Stata Tech Bull. Multifacility outbreak of middle east respiratory syndrome in Taif, Saudi Arabia. CrossRefPubMedPubMedCentralZurück zum Zitat Badawi A, Ryoo SG. Glad i could help you Add some more screenshots. 2020. https://doi.org/10.1183/13993003.00310-2020. Stockholm: ECDC; 2020.Zurück zum Zitat Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Cookies allow us to distinguish you from other users of our website, personalise content and ads, provide social media features and analyse your use of this website. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis. The crude CFRs increased significantly with increasing number of chronic comorbid conditions, ranging from 6% for at least one chronic comorbid condition to 13% for 2 or 3 chronic comorbid conditions, 12% for 4 chronic comorbid conditions, 14% for 5 chronic comorbid conditions, and 21% for 6 or more chronic comorbid conditions. https://doi.org/10.1093/cid/ciaa272.Zurück zum Zitat Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al.
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. N Engl J Med. 2012;2:a007724. CrossRefZurück zum Zitat De Toledo IP, Stefani FM, Porporatti AL, Mezzomo LA, Peres MA, Flores-Mir C, et al. Bitte aktivieren Sie Java-Script in Ihrem Browser, damit Sie alle Vorteile und Funktionen dieser Website nutzen können.Die aktuelle Entwicklung zu SARS-CoV-2 (2019-nCoV) und der Lungenkrankheit COVID-19 im Überblick.
CrossRefZurück zum Zitat Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. The most prevalent chronic comorbid conditions were: any type of chronic comorbidity (37%; 95% CI 32–41%), hypertension (22%; 95% CI 17–27%), diabetes (14%; 95% CI 12–17%), respiratory diseases (5%; 95% CI 3–6%), cardiovascular diseases (13%; 95% CI 10–16%) and other chronic diseases (e.g., cancer) (8%; 95% CI 6–10%).
CrossRefPubMedPubMedCentralhttps://doi.org/10.1016/j.ijid.2016.06.015Zurück zum Zitat Yang YM, Hsu CY, Lai CC, Yen MF, Wikramaratna PS, Chen HH, et al. 2020. https://doi.org/10.1016/j.ijcard.2020.03.063. Prog Cardiovasc Dis. Lancet Infect Dis. https://doi.org/10.1016/S0140-6736(20)30558-4. CrossRefZurück zum Zitat Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. 2020;133:1025–1031.Zurück zum Zitat Wu Z, McGoogan JM. Aktuelle, verlässliche Information und Fortbildung für Ärzte im Berufsalltag. 2020;395:497–506. Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK—sixth update—12 March 2020. I just now got the error that some of ya'll are having with using the USB-BOOT. Please check out JavaScript is disabled.
Impact of comorbidity on fatality rate of patients with middle east respiratory syndrome. I see you took my advice and used the ATIflash instead of trying to flash your cards in windows. Useful multi colour LED and a good neutral spread on the low light unfocused white light. 2020;395:507–13.
CrossRefZurück zum Zitat Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al.